Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 346

2.

Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocol.

Alexander JH, Jordan SW, West JM, Compston A, Fugitt J, Bowen JB, Dumanian GA, Pollock R, Mayerson JL, Scharschmidt TJ, Valerio IL.

J Surg Oncol. 2019 Sep;120(3):348-358. doi: 10.1002/jso.25586. Epub 2019 Jun 13.

PMID:
31197851
3.

150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein's legacy.

Lehmann HC, Compston A, Hartung HP.

Neurology. 2018 May 29;90(22):1011-1016. doi: 10.1212/WNL.0000000000005613.

PMID:
29807916
4.

Editorial.

Compston A.

Brain. 2018 Jun 1;141(6):1577-1579. doi: 10.1093/brain/awy130. No abstract available.

PMID:
29800476
5.

From the Archives.

Compston A.

Brain. 2018 Apr 1;141(4):1229-1233. doi: 10.1093/brain/awy037. No abstract available.

PMID:
29596664
6.

Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.

Smets I, Fiddes B, Garcia-Perez JE, He D, Mallants K, Liao W, Dooley J, Wang G, Humblet-Baron S, Dubois B, Compston A, Jones J, Coles A, Liston A, Ban M, Goris A, Sawcer S.

Brain. 2018 Mar 1;141(3):786-796. doi: 10.1093/brain/awx372.

7.

Parkinson's disease - the story of an eponym.

Goedert M, Compston A.

Nat Rev Neurol. 2018 Jan;14(1):57-62. doi: 10.1038/nrneurol.2017.165. Epub 2017 Dec 8. Review.

PMID:
29217826
9.

Sir Henry Head FRS (1861-1940): a life in science and society.

Compston A.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):716-717. doi: 10.1136/jnnp-2017-315967. Epub 2017 Jun 1. No abstract available.

PMID:
28572276
11.

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.

Dendrou CA, Cortes A, Shipman L, Evans HG, Attfield KE, Jostins L, Barber T, Kaur G, Kuttikkatte SB, Leach OA, Desel C, Faergeman SL, Cheeseman J, Neville MJ, Sawcer S, Compston A, Johnson AR, Everett C, Bell JI, Karpe F, Ultsch M, Eigenbrot C, McVean G, Fugger L.

Sci Transl Med. 2016 Nov 2;8(363):363ra149.

12.

John Walton, Lord Walton of Detchant: a man of influence and goodwill.

Compston A.

Brain. 2016 Dec;139(Pt 12):3314-3324. Epub 2016 Nov 1. No abstract available.

PMID:
27803016
13.
14.

Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.

Ossola B, Zhao C, Compston A, Pluchino S, Franklin RJ, Spillantini MG.

Glia. 2016 Mar;64(3):457-71. doi: 10.1002/glia.22940. Epub 2015 Nov 18.

15.

Acting on incidental findings in research imaging.

Wardlaw JM, Davies H, Booth TC, Laurie G, Compston A, Freeman C, Leach MO, Waldman AD, Lomas DJ, Kessler K, Crabbe F, Jackson A.

BMJ. 2015 Nov 10;351:h5190. doi: 10.1136/bmj.h5190. No abstract available.

PMID:
26556813
16.

From The Archives.

Compston A.

Brain. 2015 Aug;138(Pt 8):2455-9. No abstract available.

PMID:
26425747
17.

Class II HLA interactions modulate genetic risk for multiple sclerosis.

Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A, Gourraud PA, Graetz C, Hemmer B, Hillert J; International IBD Genetics Consortium (IIBDGC), Kockum I, Leslie S, Lill CM, Martinelli-Boneschi F, Oksenberg JR, Olsson T, Oturai A, Saarela J, Søndergaard HB, Spurkland A, Taylor B, Winkelmann J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CCA, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Hauser SL, De Jager PL, Compston A, McCauley JL, Sawcer S, McVean G.

Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.

19.

Dorsal column.

Compston A.

Brain. 2014 Oct;137(Pt 10):2862-7. No abstract available.

PMID:
25353035
20.

From the archives.

Compston A.

Brain. 2014 Jul;137(Pt 7):2099-104. No abstract available.

PMID:
25089312
21.

Dorsal column. From the archives.

Compston A.

Brain. 2014 May;137(Pt 5):1565-7. No abstract available.

PMID:
24892182
22.

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Kousin-Ezewu O, Azzopardi L, Parker RA, Tuohy O, Compston A, Coles A, Jones J.

Neurology. 2014 Jun 17;82(24):2158-64. doi: 10.1212/WNL.0000000000000520. Epub 2014 May 16.

23.

Dorsal column. From the archives.

Compston A.

Brain. 2014 Apr;137(Pt 4):1266-71. No abstract available.

PMID:
24783240
24.

Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.

Kemppinen AK, Baker A, Liao W, Fiddes B, Jones J, Compston A, Ban M, Sawcer S.

Mult Scler. 2014 Oct;20(12):1564-8. doi: 10.1177/1352458514529613. Epub 2014 Apr 16.

PMID:
24740369
25.

From the archives.

Compston A.

Brain. 2014 Feb;137(Pt 2):640-4. Review. No abstract available.

PMID:
24633579
26.

Product licences for alemtuzumab and multiple sclerosis.

Coles AJ, Compston A; 70 signatories.

Lancet. 2014 Mar 8;383(9920):867-8. doi: 10.1016/S0140-6736(14)60440-2. No abstract available.

PMID:
24607095
27.

Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.

Azzopardi L, Thompson SA, Harding KE, Cossburn M, Robertson N, Compston A, Coles AJ, Jones JL.

J Neurol Neurosurg Psychiatry. 2014 Jul;85(7):795-8. doi: 10.1136/jnnp-2013-307042. Epub 2013 Dec 24.

PMID:
24368840
28.

Brain. Editorial.

Compston A.

Brain. 2013 Dec;136(Pt 12):3515-9. doi: 10.1093/brain/awt335. No abstract available.

PMID:
24335050
29.

High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology.

Stacpoole SR, Spitzer S, Bilican B, Compston A, Karadottir R, Chandran S, Franklin RJ.

Stem Cell Reports. 2013 Oct 31;1(5):437-50. doi: 10.1016/j.stemcr.2013.09.006. eCollection 2013.

30.

Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.

Jones JL, Thompson SA, Loh P, Davies JL, Tuohy OC, Curry AJ, Azzopardi L, Hill-Cawthorne G, Fahey MT, Compston A, Coles AJ.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20200-5. doi: 10.1073/pnas.1313654110. Epub 2013 Nov 26.

31.

No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ; International Multiple Sclerosis Genetics Consortium, van Es M; Australia and New Zealand MS Genetics Consortium, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH Jr, Shatunov A, Leigh N, Al-Chalabi A, Shaw CE, Traynor BJ, Chiò A, Restagno G, Mora G, Ophoff RA, Oksenberg JR, Van Damme P, Compston A, Robberecht W, Dubois B, van den Berg LH, De Jager PL, Veldink JH, de Bakker PI.

Hum Mol Genet. 2014 Apr 1;23(7):1916-22. doi: 10.1093/hmg/ddt574. Epub 2013 Nov 13.

32.

From the archives.

Compston A.

Brain. 2013 Oct;136(Pt 10):2928-32. Review. No abstract available.

PMID:
24195127
33.

Down the ages, physicians have observed the evolution of disease over time.

Compston A.

Brain. 2013 Nov;136(Pt 11):3205-8. doi: 10.1093/brain/awt307. No abstract available.

PMID:
24163363
34.

A new familial infantile form of diffuse brain-sclerosis.

Compston A.

Brain. 2013 Sep;136(Pt 9):2649-51. No abstract available.

PMID:
24137751
35.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelčić I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Leppä V, Liberatore G, Lie BA, Lill CM, Lindén M, Link J, Luessi F, Lycke J, Macciardi F, Männistö S, Manrique CP, Martin R, Martinelli V, Mason D, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, Rog D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra M, Spurkland A, Strange A, Sundqvist E, Thijs V, Thorpe J, Ticca A, Tienari P, van Duijn C, Visser EM, Vucic S, Westerlind H, Wiley JS, Wilkins A, Wilson JF, Winkelmann J, Zajicek J, Zindler E, Haines JL, Pericak-Vance MA, Ivinson AJ, Stewart G, Hafler D, Hauser SL, Compston A, McVean G, De Jager P, Sawcer SJ, McCauley JL.

Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.

36.

Brain editorial.

Compston A.

Brain. 2013 Oct;136(Pt 10):2925-7. doi: 10.1093/brain/awt261. No abstract available.

PMID:
24072483
37.

From the archives. A contribution to the study of apraxia with a review of the literature.

Compston A.

Brain. 2013 Aug;136(Pt 8):2331-5. No abstract available.

PMID:
24046837
38.

Brain. Editorial.

Compston A.

Brain. 2013 Sep;136(Pt 9):2645-8. doi: 10.1093/brain/awt235. No abstract available.

PMID:
23983025
39.

From the archives.

Compston A.

Brain. 2013 Jul;136(Pt 7):2011-4. No abstract available.

PMID:
23967476
40.

Genetic burden in multiple sclerosis families.

Isobe N, Damotte V, Re VL, Ban M, Pappas D, Guillot-Noel L, Rebeix I, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gourraud PA.

Genes Immun. 2013 Oct;14(7):434-440. doi: 10.1038/gene.2013.37. Epub 2013 Aug 1.

42.

Brain. Editorial.

Compston A.

Brain. 2013 Aug;136(Pt 8):2327-30. doi: 10.1093/brain/awt217. No abstract available.

PMID:
23884807
43.

Brain. Editorial.

Compston A.

Brain. 2013 Jul;136(Pt 7):2007-10. doi: 10.1093/brain/awt173. No abstract available.

PMID:
23801733
44.

Confounding underlies the apparent month of birth effect in multiple sclerosis.

Fiddes B, Wason J, Kemppinen A, Ban M, Compston A, Sawcer S.

Ann Neurol. 2013 Jun;73(6):714-20. doi: 10.1002/ana.23925. Epub 2013 Jul 2.

45.

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium, Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, Pérez J, Damotte V, Booth D, Lopez de Lapuente A, Broer L, Schilling M, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Blaschke P, Buttmann M, Chan A, Compston A, Cournu-Rebeix I, Dörner T, Epplen JT, Fernández Ó, Gerdes LA, Guillot-Noël L, Hartung HP, Hoffjan S, Izquierdo G, Kemppinen A, Kroner A, Kubisch C, Kümpfel T, Li SC, Lindenberger U, Lohse P, Lubetzki C, Luessi F, Malhotra S, Mescheriakova J, Montalban X, Papeix C, Paredes LF, Rieckmann P, Steinhagen-Thiessen E, Winkelmann A, Zettl UK, Hintzen R, Vandenbroeck K, Stewart G, Fontaine B, Comabella M, Urcelay E, Matesanz F, Sawcer S, Bertram L, Zipp F.

Brain. 2013 Jun;136(Pt 6):1778-82. doi: 10.1093/brain/awt101.

46.

Brain. Editorial.

Compston A.

Brain. 2013 Jun;136(Pt 6):1677-80. doi: 10.1093/brain/awt137. No abstract available.

PMID:
23739913
47.

Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.

Hunt KA, Mistry V, Bockett NA, Ahmad T, Ban M, Barker JN, Barrett JC, Blackburn H, Brand O, Burren O, Capon F, Compston A, Gough SC, Jostins L, Kong Y, Lee JC, Lek M, MacArthur DG, Mansfield JC, Mathew CG, Mein CA, Mirza M, Nutland S, Onengut-Gumuscu S, Papouli E, Parkes M, Rich SS, Sawcer S, Satsangi J, Simmonds MJ, Trembath RC, Walker NM, Wozniak E, Todd JA, Simpson MA, Plagnol V, van Heel DA.

Nature. 2013 Jun 13;498(7453):232-5. doi: 10.1038/nature12170. Epub 2013 May 22.

48.

Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease.

Blakely EL, Yarham JW, Alston CL, Craig K, Poulton J, Brierley C, Park SM, Dean A, Xuereb JH, Anderson KN, Compston A, Allen C, Sharif S, Enevoldson P, Wilson M, Hammans SR, Turnbull DM, McFarland R, Taylor RW.

Hum Mutat. 2013 Sep;34(9):1260-8. doi: 10.1002/humu.22358.

49.

Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantation.

Stacpoole SR, Webber DJ, Bilican B, Compston A, Chandran S, Franklin RJ.

Stem Cells Transl Med. 2013 Jun;2(6):464-72. doi: 10.5966/sctm.2012-0144. Epub 2013 May 15.

50.

From the archives.

Compston A.

Brain. 2013 Apr;136(Pt 4):990-3. No abstract available.

PMID:
23667936

Supplemental Content

Loading ...
Support Center